57. Idiopathic dilated cardiomyopathy
12 clinical trials,   25 drugs   (DrugBank: 12 drugs),   9 drug target genes,   33 drug target pathways
Searched query = "Idiopathic dilated cardiomyopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02256501 (ClinicalTrials.gov) | June 2013 | 1/10/2014 | Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy | Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathic Dilated Cardiomyopathy in Pediatric Patients: Clinical Trial Phase I/II | Cardiomyopathy | Biological: Mono Nuclear Cell (MNC) transplantation | Nasser Aghdami MD., PhD | NULL | Completed | 1 Year | 16 Years | All | 30 | Phase 1;Phase 2 | Iran, Islamic Republic of |